Quantcast

Latest Raloxifene Stories

2014-05-29 23:08:25

According to a new report from BCC Research,the global market for women’s health therapeutics is expected to grow to $22.5 billion by 2018, with a five-year compound annual growth rate (CAGR) of 3.5%. The postmenopausal osteoporosis therapeutics segment leads the global market, claiming 53% market share. Wellesley, Mass., (PRWEB) May 29, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, Therapeutics for Women's Health: Technologies and Global Markets, the...

2014-04-01 08:30:33

- Prasco to market the Authorized Generic of EVISTA® in the United States CINCINNATI, April 1, 2014 /PRNewswire/ -- Prasco Laboratories, announced today it has signed a marketing and distribution agreement with Eli Lilly and Company (NYSE: LLY) to market the Authorized Generic (AG) version of EVISTA(®) (raloxifene hydrochloride tablets), in 60 mg strength in the United States. Prasco will begin shipping the product immediately. The financial terms of the agreement were not...

2014-01-17 23:03:42

Certain medications can reduce a woman's risk for developing breast cancer. Women at high risk for breast cancer should talk with their doctors about this strategy. Boston, MA (PRWEB) January 17, 2014 Many new and potent medicines to prevent breast cancer have become available in the past 20 years. Surprisingly, many women—even those at high risk for the disease—are not taking advantage of these medicines, according to an article in the January 2014 issue of the Harvard...

Reducing Risk Of Breast Cancer With Promising New Drug Treatment
2013-12-12 10:25:15

Rebekah Eliason for redOrbit.com – Your Universe Online There is good news for postmenopausal women who are at high risk for developing breast cancer. According to a new study, taking the drug anastrozole for five years reduced the likelihood of developing the disease by 53 percent when compared with women who took a placebo. Approximately 80 percent of women in the United States who are diagnosed with breast cancer have tumors that contain high levels of hormone receptors. These...

2013-07-16 23:22:35

ASCO expert panel includes University of New England researcher Nananda Col, M.D., M.P.H. Biddeford, ME (PRWEB) July 16, 2013 The American Society of Clinical Oncology (ASCO) has announced important updates to its 2009 Breast Cancer Risk Reduction Guidelines. Nananda Col, M.D., M.P.H., professor of medicine at the University of New England's College of Osteopathic Medicine and faculty member in the Center for Excellence in the Neurosciences, is a member of the ASCO panel that...

Genetic Markers May Signify Response To Breast Cancer Therapy
2013-06-13 19:09:12

Brett Smith for redOrbit.com — Your Universe Online New research from the Mayo Clinic has identified favorable genetic variations that increase the chances of a positive response to preventive breast cancer therapy with the drugs tamoxifen and raloxifene, according to a new report in the journal Cancer Discovery. "Our findings are important because we identified genetic factors that could eventually be used to select women who should be offered the drugs for prevention,"...

Discovery Of New Genes May Help Assess Risk And Prevent Breast Cancer
2013-03-20 10:17:03

April Flowers for redOrbit.com - Your Universe Online A new study from Northwestern Medicine has identified a set of genes that may predict which women are at high risk for getting breast cancer that is sensitive to estrogen. These women would be helped by taking drugs to prevent the cancer's development. The results of the study will be published in the journal Cancer Prevention Research. "We now have the possibility of predicting if a preventive drug will work for a woman at high...

2012-04-16 10:06:58

Tailored, web-based intervention helped women understand options When women at high risk of breast cancer viewed a customized web-based decision guide about prevention options, they were more likely to make a choice about prevention and to feel comfortable with their choice, a new study finds. Researchers developed a web-based tool called the Guide to Decide, which included general information about breast cancer and personalized information about an individual woman's five-year risk of...

2011-08-09 07:00:00

INDIANAPOLIS, Aug. 9, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published online in Current Medical Research & Opinion. The review includes summaries of previously published information; new, previously unpublished observations; and new data on EVISTA use. EVISTA is indicated for the treatment of osteoporosis in postmenopausal women and reduction in risk of...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related